ReviewCureus2022

Pulmonary Function Tests as a Biomarker in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia Patients Treated With Somatostatin Analogues.

Heer V Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.